Nova Eye Medical Limited (ASX:EYE)
Australia · Delayed Price · Currency is AUD 0.1400
+0.0050 (3.70%)
Sep 17, 2026, 3:53 PM AEST
Nova Eye Medical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -4.33 | -9.06 | -8.79 | -15.29 | -7.5 |
Depreciation & Amortization | 1.63 | 1.74 | 2.42 | 2.3 | 1.81 |
Other Amortization | 0.54 | 0.52 | 0.57 | - | - |
Asset Writedown & Restructuring Costs | - | - | - | 6.04 | - |
Stock-Based Compensation | 0.09 | 0.09 | 0.04 | 0.18 | 0.2 |
Other Operating Activities | -0.18 | 1.09 | -0.13 | -0.24 | -1.63 |
Change in Accounts Receivable | -0.98 | -0.1 | -1.86 | -0 | 1.82 |
Change in Inventory | -0.36 | 0.29 | -0.48 | -0.27 | -0.64 |
Change in Accounts Payable | 0.07 | -1.22 | -0.8 | 0.53 | 0.54 |
Change in Income Taxes | - | - | 0.88 | 0.69 | -0.16 |
Change in Other Net Operating Assets | 0.37 | 0.5 | 0.28 | 0.21 | 0.01 |
Operating Cash Flow | -3.15 | -6.15 | -7.86 | -6.82 | -4.72 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.24 | -0.3 | -0.21 | -0.26 | -0.13 |
Divestitures | - | - | - | - | 2.02 |
Sale (Purchase) of Intangibles | -0.15 | -0.15 | -0.24 | -0.54 | -5.46 |
Other Investing Activities | 0.03 | 0.09 | 0.12 | 0.1 | -0.97 |
Investing Cash Flow | -0.36 | -0.36 | -0.33 | -0.7 | -4.54 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | -0.66 | -0.61 | -0.52 | -0.65 | -0.4 |
Lease Payments | -0.66 | -0.61 | -0.52 | -0.65 | -0.4 |
Net Debt Issued (Repaid) | -0.66 | -0.61 | -0.52 | -0.65 | -0.4 |
Issuance of Common Stock | - | 6.17 | 7.43 | 7.47 | - |
Financing Cash Flow | -0.66 | 5.56 | 6.91 | 6.82 | -0.4 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 0.08 | -0.14 | 0 | 0.12 | -0.14 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - |
Net Cash Flow | -4.09 | -1.1 | -1.27 | -0.58 | -9.8 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -3.38 | -6.45 | -8.07 | -7.09 | -4.85 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -9.70% | -22.03% | -34.59% | -41.63% | -36.27% |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.04 | -0.03 |
Levered Free Cash Flow | -1.95 | -3.17 | -4.92 | -3 | -8.17 |
Unlevered Free Cash Flow | -1.85 | -3.07 | -4.88 | -2.96 | -8.13 |
Free Cash Flow After Leases | -4.04 | -7.06 | -8.59 | -7.74 | -5.25 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.13 | 0.16 | 0.06 | 0.05 | 0.06 |
Cash Income Tax Paid | - | - | -0.88 | -1.4 | -1.42 |
Change in Working Capital | -0.89 | -0.53 | -1.97 | 0.19 | 2.39 |